Description
METABOLOMICS TESTING
First action · last action
2019-03-07 · 2019-03-07
Transactions
1
First transaction's obligation
$18,000
Base + all options value (sum of deltas)
$18,000
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-03-07+$18,000= $18,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-03-07 | +$18,000 | $18,000 | METABOLOMICS TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SBY5A7EK9PU3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826P1227 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $20,240 | FY2026 |
| 36C24E26N0076 | RPO EAST (36C24E) · AN41 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH | $636,000 | FY2026 |
| 36C24E25N0098 | RPO EAST (36C24E) · AN41 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH | $864,000 | FY2025 |
| 36C24E24N0078 | RPO EAST (36C24E) · AN41 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH | $2,999,820 | FY2024 |
| 36C24624P0374 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · AN42 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | $261,500 | FY2024 |
| 36C26223N0718 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $0 | FY2023 |
Other recipients under Q301 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26026N0312 | SLEEP CARE, INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $68,520 | FY2026 |
| 36C26026P0708 | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $19,500 | FY2026 |
| 36C26026N0421 | BLOODWORKS | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $40,000 | FY2026 |
| 36C26026P0562 | UNIVERSITY OF CALIFORNIA, DAVIS | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $1,024 | FY2026 |
| 36C26026N0382 | DIASORIN INC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $125,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26019P0591_3600_-NONE-_-NONE- · retrieved 2026-09-26.